NCT00158847View on ClinicalTrials.gov

Modification Of Disease Outcome In COPD

PHASE4TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2000

Study Completion Date

May 31, 2005

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

fluticasone 500 mcg

DRUG

fluticasone 500 mcg + salmeterol 50 mcg

Trial Locations (2)

9700 RB

University Medical Center Groningen, Groningen

2300 RC

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

Academisch Ziekenhuis Groningen

OTHER

collaborator

The Netherlands Asthma Foundation

OTHER

collaborator

Netherlands Organisation for Scientific Research

OTHER_GOV

collaborator

GlaxoSmithKline

INDUSTRY

lead

Leiden University Medical Center

OTHER

NCT00158847 - Modification Of Disease Outcome In COPD | Biotech Hunter | Biotech Hunter